Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?

Author:

An, Julie Y [ORCID]

Harmon, Stephanie

Mehralivand, Sherif

Czarniecki, Marcin

Smith, Clayton P

Peretti, Julie A

Wood, Bradford J

Pinto, Peter A

Choyke, Peter L

Shih, Joanna H

Turkbey, Baris
Author Address

Center for Interventional Oncology, NIH Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, MD, USA., Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc, NCI Campus at Frederick, 1050 Boyle Street, Frederick, MD, USA., Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room B3B85, Bethesda, MD, 20892, USA., Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD, USA., Department of Urology and Pediatric Urology, University Medical Center, Mainz, Germany., Biometric Research Program, National Cancer Institute, National Institutes of Health, 6130 Executive Plaza, Rockville, MD, USA., Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room B3B85, Bethesda, MD, 20892, USA. turkbeyi@mail.nih.gov.,

Author Address